Drawing for REJUVENATE BIO

USPTO serial 88730466

REJUVENATE BIO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PHILLIPS, WENDELL SHARMAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REJUVENATE BIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Oliver Platz

Oliver Platz Platz Law P.C.447 Broadway2nd FloorNew York, NY 10013

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations and therapeutic agents for use in gene therapy; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of heart disease, fibrosis, inflammation, immune dysfunction, obesity, neurodegenerative disorders, cancer, sarcopenia, joint deterioration, and for the reversal and prevention of aging; pharmaceutical preparations containing adeno-associated virus (AAV) for use in the prevention, diagnosis and treatment of heart disease, fibrosis, inflammation, immune dysfunction, obesity, neurodegenerative disorders, cancer, sarcopenia, joint deterioration, and for the reversal and prevention of aging; pharmaceutical preparations for the treatment and prevention of mitral valve disease (MVD)ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 17, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 17, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 30, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 29, 2022EX5GSOU EXTENSION 5 GRANTED—
Dec 29, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 12, 2022EXT5SOU EXTENSION 5 FILED—
Dec 12, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 22, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 22, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 10, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 8, 2022EX4GSOU EXTENSION 4 GRANTED—
Jun 8, 2022EXT4SOU EXTENSION 4 FILED—
Jun 8, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 3, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 1, 2021EX3GSOU EXTENSION 3 GRANTED—
Dec 1, 2021EXT3SOU EXTENSION 3 FILED—
Dec 1, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 11, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 9, 2021EX2GSOU EXTENSION 2 GRANTED—
Jun 9, 2021EXT2SOU EXTENSION 2 FILED—
Jun 9, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 20, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 18, 2020EX1GSOU EXTENSION 1 GRANTED—
Nov 18, 2020EXT1SOU EXTENSION 1 FILED—
Nov 18, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 16, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 16, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 16, 2020DOCKASSIGNED TO EXAMINER—
Dec 20, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 20, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance